Dear CT Insider,
The American College of Radiology's Lung-RADS metric is a valuable resource for standardizing interpretations of CT lung cancer screening scans, and this fall, the college plans to release updates that will recategorize some imaging findings.
What will change? At this week's annual American Roentgen Ray Society (ARRS) meeting, Dr. Debra Dyer of National Jewish Health in Denver outlined the coming Lung-RADS updates and offered suggestions for optimizing low-dose CT lung cancer screening. Take a look at this edition's Insider Exclusive for a sneak peek.
When you've read our Exclusive, check out more of our coverage of ARRS 2022, including a story on how body composition analysis using CT shows promise, another on how COVID-19 disproportionately affected poorer communities -- a phenomenon discovered in part via patients reporting for lung cancer screening, and an article on the challenges American Indian and Alaskan Native people face when it comes to access to CT lung cancer screening.
Beyond ARRS 2022, discover what Dutch researchers have to say about the association between emphysema found on chest CT and higher lung cancer risk, and find out how automated 3D segmentation software can help radiologists identify pulmonary hypertension on CT pulmonary angiography exams.
Finally, this month we're also highlighting the following:
- What coronary CT angiography reveals about the efficacy of aspirin therapy for reducing adverse events caused by heart disease
- How utilization rates of CT colonography -- a minimally invasive, sensitive test for identifying polyps -- could be improved
- The importance of patient positioning for reducing radiation dose during CT exams
CT has been supporting and advancing patient care for decades and is constantly evolving. We invite you to visit our CT Community on the regular to keep up with the modality's latest developments -- and if you have CT topics you'd like to see covered, feel free to contact me.
